
Education and Training
- Ph.D., North Carolina State University, 2010
Selected Grants
- Early life B cell responses and inflammation following SARS-CoV-2 infection
- Improving transplant organ survival through the mitigation of donor-derived mitochondrial damage-associated molecular patterns
- Macrogenics Research Agreement Option 2
- New Analytic Approaches and Endpoints in Human HIV Vaccine Correlate Studies
- Nonhuman Primate Option 4
- CIVICS Component A - Option 2
- Escape of maternal plasma broadly neutralizing antibody responses as a mechanism of mother to child HIV transmission
- CARE Focus 2: Clearance of HIV Antigen-Positive Cells
- Project 2: RNA vaccination in early life to induce potent and broad HIV Env-specific antibody responses
- Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques-Supplement
- HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals
- Combined Hepatitis B and HIV-1 Envelope Infant Vaccination to Augment T cell Help through Enhanced Linked Recognition
- Novel Recombinant Streptococcus mitis as an oral vaccine against HIV/AIDS
- CARE Focus 1: Latency Biomarker Project
- Project 2: RNA vaccination in early life to induce potent and broad HIV Env-specific antibody responses
- Primate Contract Expansion for Covid-19
- Antibody and viral determinants of protection against CMV infection following gB/MF59 vaccination
- Exploring Dual-Affinity Re-Targeting Proteins for Cure of Pediatric HIV-1 Infection
- Creation of a bnAbnectin
- CARE Duke-UNC Latency Biomarker Supplement Year 2
- Exploring ADCC for cure of pediatric HIV-1 infection using a cord-blood CD4 Tcell model
- Central Laboratory for the HIV Vaccines Trial Network